WOCKPHARMA2020-10-012020-12-31in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2020-10-012020-12-31in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2020-10-012020-12-31in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2020-10-012020-12-31in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2020-04-01 2021-03-31 2021-01-21 INR Crores Third quarter Single segment Pharmaceuticals 2020-10-01 2020-12-31 Unaudited Consolidated 7640200000.00 1005400000.00 8645600000.00 1762100000.00 1842700000.00 -455400000.00 2018400000.00 598500000.00 678800000.00 1888600000.00 8333700000.00 311900000.00 0.00 311900000.00 -101200000.00 89100000.00 -12100000.00 0.00 324000000.00 0.00 0.00 0.00 0.00 324000000.00 417800000.00 741800000.00 152400000.00 171600000.00 650300000.00 91500000.00 553900000.00 5 1.38 1.37 0.00 0.00 1.38 1.37 Notes To consolidated Results:- n n1. For Notes to Consolidated Results please refer the notes from the Statement of Consolidated Unaudited Results for the quarter ended and nine months ended 31.12.2020 as attached which is submitted under Outcome of Board Meeting today. n n2. Income represents Income from continuing operations, Expenses represents Expenses from continuing operations, Exceptional items represents Exceptional items-charge from Continuing Operations, Tax expense represents Tax expense of continuing operations, Total profit before exceptional items and tax represents Profit/(Loss) before exceptional items and tax from Continuing Operations, Total profit before tax represents Profit/(Loss) after exceptional items and before tax from Continuing Operations and Profit / (Loss) from discontinued operations before tax represents Profit after exceptional items and before tax from Discontinued Operations. Net Profit / (Loss) from discontinued operations after tax represents Profit from Discontinued Operations. n n3. Profit / (Loss) from Discontinued Operations before tax for nine months ended 31.12.2020 includes Profit before exceptional items and tax from Discontinued Operations Rs. 13.87 crore and Exceptional items- credit / (charge)- Discontinued Operations Rs. 1470.32 crore n n4. Tax expense represents Tax expense of continuing operations which includes Current tax - credit of Rs. 10.12 crore and Rs 88.41 crore for quarter ended 31.12.2020 and nine months ended 31.12.2020 respectively; and Deferred tax-charge of Rs. 8.91 crore for quarter ended 31.12.2020 and Deferred tax - credit Rs. 111.86 crore for nine months ended 31.12.2020. n n5. Tax expense of discontinued operations for nine months ended 31.12.2020 includes Current tax - charge of Rs. 311.49 crore and Deferred tax - charge of Rs. 187.37 crore n n6. Diluted EPS from continuing and discontinued operations for nine months ended 31.12.2020 is Rs. 70.03 instead of Rs. 69.96 calculated as per table. n n7. EPS for the quarter and nine months ended 31.12.2020 from Continuing operations, Discontinued operations and Continuing and Discontinued operations is not annualised. n nOCI Segment: n8. Income tax relating items that will not be classified to Profit or loss includes income tax relating to items that will not be reclassified to Profit or loss from Continuing operations and Discontinued operations. Single segment 2020-04-01 2020-12-31 Unaudited Consolidated 20763400000.00 1247300000.00 22010700000.00 5105200000.00 4707000000.00 -1550000000.00 6017000000.00 1944500000.00 1809900000.00 6453900000.00 24487500000.00 -2476800000.00 -1424800000.00 -3901600000.00 -884100000.00 -1118600000.00 -2002700000.00 0.00 -1898900000.00 14841900000.00 4988600000.00 9853300000.00 0.00 7954400000.00 518900000.00 8473300000.00 7788500000.00 165900000.00 8359900000.00 113400000.00 553900000.00 5 -18.64 -18.64 88.97 88.60 70.33 69.96 Exchange fluctuation loss / (gain), net -25900000.00 Other expenses 1914500000.00 Exchange fluctuation loss / (gain), net 166600000.00 Other expenses 6287300000.00